Showing results (1251-1260 of 6,507) with videos related to
Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|April 17, 2023
The pathogenetic significance of exhausted T cells in a mouse model of mature B cell neoplasmsAsuka Shibamiya, Yurie Miyamoto-Nagai, Shuhei Koide, et al.Cancer Immunology, Immunotherapy : CII|April 3, 2023
Integrative analyses of bulk and single-cell RNA-seq identified cancer-associated fibroblasts-related signature as a prognostic factor for immunotherapy in NSCLCShasha Wang, Guangyu Fan, Lin Li, et al.Cancer Immunology, Immunotherapy : CII|April 5, 2023
Multidisciplinary recommendations for essential baseline functional and laboratory tests to facilitate early diagnosis and management of immune-related adverse events among cancer patientsBerna C Özdemir, Cristina Espinosa da Silva, Dimitri Arangalage, et al.Cancer Immunology, Immunotherapy : CII|April 5, 2023
Combined therapeutic effect of YHO-1701 with PD-1 blockade is dependent on natural killer cell activity in syngeneic mouse modelsHiroyuki Takahashi, Nao Miyoshi, Hisashi Murakami, et al.Cancer Immunology, Immunotherapy : CII|March 30, 2023
Immune checkpoint inhibition combined with targeted therapy using a novel virus-like drug conjugate induces complete responses in a murine model of local and distant tumorsRuben V Huis In 't Veld, Sen Ma, Rhonda C Kines, et al.Cancer Immunology, Immunotherapy : CII|April 4, 2023
Factors impacting the efficacy of the in-situ vaccine with CpG and OX40 agonistAlexander A Pieper, Dan V Spiegelman, Mildred A R Felder, et al.Cancer Immunology, Immunotherapy : CII|April 5, 2021
Bruton's tyrosine kinase: an emerging targeted therapy in myeloid cells within the tumor microenvironmentLogan Good, Brooke Benner, William E CarsonCancer Immunology, Immunotherapy : CII|January 1, 1988
The intraperitoneal delivery of radiolabeled monoclonal antibodies: studies on the regional delivery advantageR L Wahl, J Barrett, O Geatti, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1988
Parameters involved in the enhancement of monoclonal antibody targeting in vivo with recombinant interferonF Guadagni, J Schlom, S Pothen, et al.Cancer Immunology, Immunotherapy : CII|January 1, 1988
Differential sensitivity to natural cell-mediated cytotoxicity of two rat colon adenocarcinoma variants differing in their tumorigenicity: identification of the effector cells as natural killer cellsH Pelletier, N O Olsson, C Fady, et al.Pageof 651